Get started
Author

Eric Hyungseok Baek

Observed names: Baek, Eric Hyungseok, E.H. Baek, Eric Baek, Hyungseok Baek
ORCID: 0000-0002-7286-7215
Observed ORCID: 0000-0002-7286-7215
OpenAlex ID: A5017221341
Autophagy and its implication in Chinese hamster ovary cell culture
2013 · Yeon Jung Kim, Eric Baek, et al. · Biotechnology Letters · 43
Effect of culture pH on recombinant antibody production by a new human cell line, F2N78, grown in suspension at 33.0 °C and 37.0 °C
2013 · Jin Seok Seo, Yeon Jung Kim, et al. · Applied Microbiology and Biotechnology · 25
Chemical inhibition of autophagy: Examining its potential to increase the specific productivity of recombinant CHO cell lines
2016 · Eric Baek, Che Lin Kim, et al. · Biotechnology and Bioengineering · 24
Anti-Apoptosis Engineering for Improved Protein Production from CHO Cells
2017 · Eric Baek, Soo Min Noh, et al. · Methods in molecular biology · 22
Effect of glucose feeding on the glycosylation quality of antibody produced by a human cell line, F2N78, in fed-batch culture
2014 · Jin Seok Seo, Byung Sup Min, et al. · Applied Microbiology and Biotechnology · 20
Untangling the mechanism of 3‐methyladenine in enhancing the specific productivity: Transcriptome analysis of recombinant Chinese hamster ovary cells treated with 3‐methyladenine
2018 · Eric Baek, Jae Seong Lee, et al. · Biotechnology and Bioengineering · 12
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial
2023 · Justin Stebbing, Yauheni Baranau, et al. · BioDrugs · 6
PDF
Cell Engineering for Therapeutic Protein Production
2014 · Eric Baek, Che Lin Kim, et al. · Cell engineering · 5
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study
2024 · Min Ho Park, Jae Hong Seo, et al. · Expert Opinion on Biological Therapy · 2
PDF
Antiapoptosis Engineering for Improved Protein Production from CHO Cells
2024 · Eric Baek, Soo Min Noh, et al. · Methods in molecular biology · 1
Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin® and US-Avastin® in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung Cancer
2026 · Taekyung Kim, Heungjo Kim, et al. · BioDrugs
PDF
Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer
2025 · Zoran Andric, Fedor Moiseenko, et al. · Cancer Treatment and Research Communications
Real-world safety and effectiveness of CT-P6 (biosimilar trastuzumab): A post-marketing surveillance study in Korea.
2023 · Min-Ho Park, Tea Hyun Kim, et al. · Journal of Clinical Oncology
185P Long-term efficacy of trastuzumab biosimilar CT-P6 in patients with HER2-positive early breast cancer: 6-year survival analysis of phase III study results
2022 · J. Stebbing, Y. Baranau, et al. · Annals of Oncology
PDF
Effect of Beclin-1 overexpression on the specific antibody productivity of recombinant Chinese hamster ovary (CHO) cells
2014 · Eric Baek, Gyun Min Lee · 한국생물공학회 학술대회
Works count: 16
Citation count: 160
H-index: 6
I10-index: 6
Year
Topic
Type